Medicenna Therapeutics, Inc
- Biotech or pharma, therapeutic R&D
Medicenna is a clinical stage immunotherapy company developing novel and highly differentiated engineered long-acting Superkines and Bifunctional SuperKines for ImmunoTherapies (BiSKITs) for treatment of advanced solid tumours, autoimmune diseases and inflammation.
We leverage our proprietary IL-2, IL-4 and IL-13 Superkine and BiSKIT platforms either on their own or in combination with other treatment modalities (immune checkpoints, BiTES, ADCs, radiotherapy, CARs, TILs, etc) for safe and highly efficacious options addressing unmet needs where conventional immunotherapies have failed.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}